Value, Affordability, and Decision Making
Efficient decisions about allocating health care budgets require assessment of the effects of health care interventions and the value for money they provide. Decision-making processes leading to funding decisions should be structured and evidence-based.
Multi-Criteria Decision Analysis to Value Orphan Medicines
1 May 2013
The purpose of this research is to identify the attributes to include in a value framework for orphan medicinal products (OMPs), determine their relative importance using…
Projecting Expenditure on Medicines in the NHS
4 January 2013
Medicines account for less than 10% of total NHS expenditure in the UK. Because spending on medicines is easy to separate out, however, this sector continues…
New Research by OHE and University of Glasgow on cost of QALYs in Scotland
17 December 2012
New health care technologies often improve health but also increase costs. Judging whether they are good value for money involves comparing what QALYs are gained from…
New Findings: Public Attitudes Towards End-of-Life Treatment in England and Wales
7 December 2012
In 2009, the UK’s National Institute for Health and Clinical Excellence (NICE) issued supplementary advice that its Appraisal Committees are to consider when assessing treatments that…
Value Based Pricing in Sweden: Lessons for Design?
28 November 2012
OHE has just published a Seminar Briefing by Ulf Persson, head of the Swedish Institute of Health Economics, which reviews experience with the Swedish value based…
NICE’s Social Value Judgments: A Closer Look at Progress
30 May 2012
Now out as a “FirstView” article in Health Economics, Policy and Law is an important analysis on the inclusion of social value judgments in NICE guidance,…
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 May 2012
Just out is an OHE Research Paper that examines the issues. The authors note that diagnostics not only facilitate health gain and cost savings, but also…
New Research on VBP: Disease Severity and Unmet Need in the UK
24 April 2012
The UK Department of Health’s value based pricing (VBP) Consultation Document proposes a process whereby higher prices would be granted to medicines that tackle diseases that…
NICE’s Social Value Judgments about Equity in Health and Health Care
17 January 2012
The National Institute for Health and Clinical Excellence (NICE) routinely publishes details of the evidence and reasoning underpinning its recommendations, including its social value judgments. To…